Suicide News

Childhood cancer survivors in Europe exhibited higher risk for suicidal ideation than the general population, according to results of a systematic review and meta-analysis.

The increasingly popular obesity and diabetes drugs known as glucagon-like peptide-1 receptor agonists do not seem to worsen suicidality despite previous concerns, according to recent data published in BMJ.

A death from suicide occurs every 43 seconds worldwide annually, according to an analysis published in The Lancet Public Health.

Many mental health care clinicians screen for firearm access and are confident in their ability to implement such screening, a research letter in JAMA Network Open showed.

Individuals with a moderate to high risk for obstructive sleep apnea, as measured via the STOP-Bang questionnaire, were more likely to experience suicidal ideations, plans and attempts, according to research conducted in South Korea.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health issues, recent data suggest they may improve brain health.

The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously developed drugs, according to data in a research latter published in JAMA Network Open.

People diagnosed with headache had a greater risk for attempting and completing suicide, according to results of a cohort study published in JAMA Neurology.

Suicide is one of the leading causes of death among youth in the United States, and pediatricians play an integral role in identifying patients who are at risk and connecting them to resources.